Collectively, the results from human and mouse models suggest that increased plasma XOR activity, mainly explained by excess hepatic leakage, was involved in the pathogenesis of vascular injury, especially in NAFLD/NASH conditions. The gene discussed is XDH; the disease is metabolic dysfunction-associated steatohepatitis.